S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
pixel
pixel
pixel
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
pixel
pixel
pixel
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
pixel
pixel
pixel
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
pixel
pixel
pixel
NYSEARCA:RXD

ProShares UltraShort Health Care Stock Forecast, Price & News

$13.29
+0.13 (+0.99 %)
(As of 09/24/2021 04:00 PM ET)
Add
Today's Range
$13.28
$13.37
50-Day Range
$12.50
$14.54
52-Week Range
$12.50
$25.10
Volume490 shs
Average Volume1,633 shs
Market Capitalization$1.06 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive RXD News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraShort Health Care and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer ProShares
Fund NameProShares UltraShort Health Care
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:RXD
Inception Date1/30/2007
Fund ManagerMichael Neches, Tarak Dave

Fund Focus

Asset ClassEquity
BenchmarkDow Jones US Healthcare Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$1.06 million
Average Daily Volume$1,610.40
Discount/Premium-0.01%

ETF Expenses

Management Fee0.75%
Other Expenses2.74%
Total Expenses3.49%
Fee Waiver-2.54%
Net Expenses0.95%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market Maker

Currency Exposure of RXD

speech bubbles
speech bubbles











ProShares UltraShort Health Care (NYSEARCA:RXD) Frequently Asked Questions

What stocks does MarketBeat like better than ProShares UltraShort Health Care?

Wall Street analysts have given ProShares UltraShort Health Care a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ProShares UltraShort Health Care wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ProShares UltraShort Health Care's stock been impacted by COVID-19?

ProShares UltraShort Health Care's stock was trading at $20.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RXD stock has decreased by 34.3% and is now trading at $13.29.
View which stocks have been most impacted by COVID-19
.

Who are ProShares UltraShort Health Care's key executives?

ProShares UltraShort Health Care's management team includes the following people:
  • Michael L. Sapir, Chairman of ProShares Trust (Age 57)
  • Louis M. Mayberg, President of ProShares Trust (Age 53)
  • Victor M. Frye Esq., Chief Compliance Officer and AML Officer of ProShares Trust (Age 56)
  • Simon D. Collier, Treasurer of ProShares Trust (Age 51)
  • Gary A. Casagrande, Assistant Treasurer of ProShares Trust (Age 40)
  • Charles S. Todd, Assistant Treasurer of ProShares Trust (Age 41)
  • Stephenie Adams, Acting Secretary of ProShares Trust (Age 43)
  • Gregory Pickard Esq., Assistant Secretary of ProShares Trust (Age 48)
  • Russell S. Reynolds III, Trustee of ProShares Trust (Age 55)
  • Michael C. Wachs, Trustee of ProShares Trust (Age 51)

What is ProShares UltraShort Health Care's stock symbol?

ProShares UltraShort Health Care trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "RXD."

Who are ProShares UltraShort Health Care's major shareholders?

ProShares UltraShort Health Care's stock is owned by a number of institutional and retail investors. Top institutional investors include Susquehanna International Group LLP (15.55%).

Which major investors are selling ProShares UltraShort Health Care stock?

RXD stock was sold by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP.

How do I buy shares of ProShares UltraShort Health Care?

Shares of RXD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ProShares UltraShort Health Care's stock price today?

One share of RXD stock can currently be purchased for approximately $13.29.

How much money does ProShares UltraShort Health Care make?

ProShares UltraShort Health Care has a market capitalization of $1.06 million.

What is ProShares UltraShort Health Care's official website?

The official website for ProShares UltraShort Health Care is www.proshares.com.

Where are ProShares UltraShort Health Care's headquarters?

ProShares UltraShort Health Care is headquartered at SUITE 1000 7501 WISCONSIN AVENUE, BETHESDA, 20814, United States.

How can I contact ProShares UltraShort Health Care?

ProShares UltraShort Health Care's mailing address is SUITE 1000 7501 WISCONSIN AVENUE, BETHESDA, 20814, United States. The company can be reached via phone at +1-240-4976400.


This page was last updated on 9/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.